Literature DB >> 10783040

Management of otitis media: 2000 and beyond.

J O Klein1.   

Abstract

BACKGROUND: In the next few years what will alter our modes of diagnosis, choice of therapies and strategies for prevention of acute otitis media (AOM)? These issues, as well as whether antibiotic resistance will continue to threaten the efficacy of currently available antimicrobial agents, whether industry and academia will be able to respond to bacterial resistance with effective new antimicrobial drugs and whether the pneumococcal conjugate vaccine will substantially reduce the incidence of AOM provide a basis for discussing the problems and possible solutions related to AOM. ANTIMICROBIAL DRUGS: Bacteria and viruses will continue to find ways to survive the activity of currently available antimicrobial drugs. Among the new antibacterial drugs under consideration are ketolides, oxazolodinones and quinolones. Guidelines stress limiting usage of antimicrobial agents to diseases that are likely caused by bacterial pathogens. Antiviral drugs are now available against influenza virus and respiratory syncytial virus infections. DIAGNOSIS: Tympanometry and/or acoustic reflectometry are adjunctive techniques for assisting in the diagnosis of middle ear effusion in children whose otoscopic examination is ambiguous. Laser myringotomy has been used in several hundred children; however, there are no published studies of randomized trials. NEW VACCINES: Investigators have evaluated the safety and efficacy of a heptavalent pneumococcal polysaccharide vaccine conjugated with CRM197 (a diphtheria toxin mutant). The results showed a reduction in the overall burden of severe and recurrent AOM. Respiratory syncytial virus is the viral pathogen most frequently associated with AOM. For this reason safe and effective viral vaccines are needed to complement the efficacy of bacterial vaccines for prevention of AOM.
CONCLUSIONS: Parents influence decisions by pediatricians to use antimicrobial agents and should be informed about the appropriate usage of antibiotics. Educators and public health officials must find techniques to distinguish WebSites that provide information of value from those that are not credible. Of paramount importance is the development of techniques to increase the accuracy of clinical and microbiologic diagnosis. Finally there is a need for studies of appropriate scientific design that can assess the efficacy and safety of alternative therapies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10783040     DOI: 10.1097/00006454-200004000-00034

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  3 in total

1.  Pharmacokinetics and efficacy of linezolid in a gerbil model of Streptococcus pneumoniae-induced acute otitis media.

Authors:  William R Humphrey; Mark H Shattuck; Raymond J Zielinski; Ming-Shang T Kuo; John J Biermacher; Donald P Smith; Jana L Jensen; Ronda D Schaadt; Gary E Zurenko; Ivan M Richards
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

2.  Biofilm formation by nontypeable Haemophilus influenzae: strain variability, outer membrane antigen expression and role of pili.

Authors:  Timothy F Murphy; Charmaine Kirkham
Journal:  BMC Microbiol       Date:  2002-04-15       Impact factor: 3.605

3.  Strain-specific virulence phenotypes of Streptococcus pneumoniae assessed using the Chinchilla laniger model of otitis media.

Authors:  Michael L Forbes; Edward Horsey; N Luisa Hiller; Farrel J Buchinsky; Jay D Hayes; James M Compliment; Todd Hillman; Suzanne Ezzo; Kai Shen; Randy Keefe; Karen Barbadora; J Christopher Post; Fen Ze Hu; Garth D Ehrlich
Journal:  PLoS One       Date:  2008-04-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.